As of June 2025, according to CVS HEALTH's latest financial report, the company's current EPS (TTM) is $4.2. In 2024, the company recorded an earnings per share (EPS) of $3.67, which represents a decrease compared to its EPS of $6.49 in 2023. CVS HEALTH's earnings per share for the quarterly report ending on Mar 31, 2025 was $1.41.
The annual EPS in 2024 was $3.67, a decrease of 43.5% from $6.49 in 2023. For the quarter ending Mar 31, 2025, the EPS was $1.41, showing a 60.2% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2025 is $4.2. In 2023, the annual EPS was $6.49, showing an increase of 97.3% from 2022.
Over the last 12 months, CVS HEALTH has registered an EPS growth of 60.2% (YoY, quarterly). Over a three-year span, the company had an average EPS growth of -15.4% per year. Over the last 5 years, the company had an average EPS growth rate of -6.4%. When measured over a ten-year period, CVS's average EPS growth rate was -0.8%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
CVS CVS HEALTH Corp | 15.06 | -43.5% | -15.4% | -6.4% |
WMT Walmart Inc | 40.3 | 26% | 14.1% | 6.8% |
PETS Petmed Express Inc | 398 | -248% | N/A | N/A |
WBA Walgreens Boots Alliance Inc | N/A | -180.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.